In contrary, medication of patients with mild to moderate atherosclerosis with rosuvastatin has been reported to cause an increase of HDL-C as well as plasma-S1P, though the increase in S1P did not reach statistical significance [ 31 ].
← all excerpts
Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans.
2
—
—
The sentences
The difference in serum-S1P between controls and atherosclerotic patients is highly significant also when PAD and CS patients are analyzed separately ( Fig 1B ).